Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-22

Clinical Trial Update: Ultra-Short Regimen for Elderly DS-TB [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an ultra-short regimen for elderly patients with drug-susceptible pulmonary tuberculosis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shenzhen Third People's Hospital | Conditions: Pulmonary Tuberculosis | Phase 3 | Status: NOT_YET_RECRUITING